What is RFXCEL?
Founded in 2003 and headquartered in Reno, Nevada, RFXCEL provides a sophisticated software ecosystem designed to enhance transparency and security throughout the pharmaceutical distribution lifecycle. The company serves a diverse clientele, including manufacturers, re-packagers, wholesalers, distributors, and dispensers. Its core technology platform is engineered to mitigate risks associated with counterfeit drugs and supply chain inefficiencies, positioning RFXCEL as a vital infrastructure provider in the life sciences industry. Through its advanced serialization and traceability solutions, the firm enables stakeholders to maintain rigorous compliance with evolving global standards, thereby safeguarding patient health and operational integrity.
How much funding has RFXCEL raised?
RFXCEL has raised a total of $30M across 1 funding round:
Series B
$30M
Series B (2017): $30M with participation from Kayne Partners
Key Investors in RFXCEL
Kayne Partners
Kayne Anderson Capital Advisors, L.P. is an alternative investment management firm with a focus on energy, infrastructure, real estate, credit, and growth equity. The firm leverages decades of experience to support high-growth companies in scaling their operational capabilities.
What's next for RFXCEL?
With the support of its recent capital injection, RFXCEL is poised to accelerate its product development roadmap and expand its footprint in emerging markets. The company is expected to focus on integrating artificial intelligence and machine learning into its existing track-and-trace architecture to provide predictive analytics for supply chain management. As regulatory scrutiny intensifies globally, RFXCEL's strategic focus will likely remain on enhancing interoperability between disparate supply chain nodes, ensuring that its enterprise-level clients can navigate the complexities of digital transformation while maintaining absolute product provenance. This phase of growth marks a transition toward broader market dominance in the pharmaceutical logistics technology sector.
See full RFXCEL company page
